In China, HPV testing has become the go-to method for spotting cervical cancer early. However, sending every woman who tests positive for HPV straight to a colposcopy is not the best use of resources. This is where triage strategies come in. They help decide who really needs that next step. A recen
Vaccines against human papillomavirus (HPV) are a big deal. They can stop cervical cancer in women and other diseases caused by HPV in anyone. Many countries have started using these vaccines. However, in many places, lots of teens still don't get the HPV shot. Why is that? There are several reasons
Cervical cancer is a big deal in the United States. It is a major health issue that affects many women. One of the main causes of this disease is the human papillomavirus, or HPV. This virus is highly preventable, making it a key target for public health efforts. To tackle this problem, health exper
HPV testing is vital for managing oropharyngeal cancer. It helps doctors understand the severity of the cancer and plan treatment. However, the frequency of this testing across the US is unclear. A recent study aimed to clarify this by examining how often HPV DNA-RNA and p16 tests are conducted for
The state of Louisiana is home to many rural communities. These communities often face significant health challenges. One such challenge is the lack of awareness about human papillomavirus. This is despite the fact that effective vaccines are available to prevent HPV infections. The issue is partic
In Mexico City, a groundbreaking effort is underway to tackle cervical cancer. The HPV-FASTER initiative is a clever mix of HPV vaccination and screening. This program is designed to reach women aged 25 to 45 in Tlalpan, a bustling area of the city. To grasp what helps or hinders women from taking p
Cervical cancer is a major health issue worldwide, even with all the progress made in screening and prevention. The way countries handle cervical cancer screening is all over the place. Some nations are still stuck with old-school methods, like cytology. This is surprising, given the solid evidence
Zimbabwe is grappling with a significant hurdle in its public health efforts. The country is struggling to achieve high vaccination rates for the human papillomavirus (HPV) among young women. This is despite clear guidelines from the World Health Organization (WHO) advocating for widespread HPV vacc
In Central Uganda, a recent study dug into why young women with HIV aren't getting the HPV vaccine. The focus was on 100 girls and young women aged 10 to 24. These young women were part of a trial in four healthcare facilities that provide antiretroviral therapy. The study happened between January a
Vulvar squamous cell carcinoma (VSCC) often begins as a precancerous condition known as high-grade vulvar intraepithelial lesion (HSIL). This condition, linked to human papillomavirus (HPV), poses a significant risk, with 8% of cases progressing to cancer. This is why it's so important to understand
